Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA179570
Max Phase: Preclinical
Molecular Formula: C10H19NO7
Molecular Weight: 265.26
Molecule Type: Small molecule
Associated Items:
ID: ALA179570
Max Phase: Preclinical
Molecular Formula: C10H19NO7
Molecular Weight: 265.26
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CCO)NCC1OC(CO)C(O)C(O)C1O
Standard InChI: InChI=1S/C10H19NO7/c12-2-1-7(14)11-3-5-8(15)10(17)9(16)6(4-13)18-5/h5-6,8-10,12-13,15-17H,1-4H2,(H,11,14)
Standard InChI Key: LAQKKQFWKYMOEJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 265.26 | Molecular Weight (Monoisotopic): 265.1162 | AlogP: -3.67 | #Rotatable Bonds: 5 |
Polar Surface Area: 139.48 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 6 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.59 | CX Basic pKa: | CX LogP: -4.07 | CX LogD: -4.07 |
Aromatic Rings: 0 | Heavy Atoms: 18 | QED Weighted: 0.30 | Np Likeness Score: 0.95 |
1. Hakamata W, Muroi M, Kadokura K, Nishio T, Oku T, Kimura A, Chiba S, Takatsuki A.. (2005) Aglycon specificity profiling of alpha-glucosidases using synthetic probes., 15 (5): [PMID:15713413] [10.1016/j.bmcl.2004.12.086] |
Source(1):